Target Information
Target General Infomation | |||||
---|---|---|---|---|---|
Target ID |
T86528
|
||||
Former ID |
TTDI02575
|
||||
Target Name |
Geranyltranstransferase
|
||||
Gene Name |
GGPS1
|
||||
Synonyms |
(2E,6E)farnesyl diphosphate synthase; Dimethylallyltranstransferase; Farnesyl diphosphate synthase; Farnesyltranstransferase; GGPP synthase; GGPPSase; Geranylgeranyl diphosphate synthase; Geranylgeranyl pyrophosphate synthase; GGPS1
|
||||
Target Type |
Research
|
||||
Disease | Bone disease [ICD10: M00-M99] | ||||
Cancer [ICD9: 140-229; ICD10: C00-C96] | |||||
Function |
Catalyzes the trans-addition of the three molecules of IPP onto DMAPP to form geranylgeranyl pyrophosphate, an important precursor of carotenoids and geranylated proteins.
|
||||
BioChemical Class |
Alkyl aryl transferase
|
||||
UniProt ID | |||||
EC Number |
EC 2.5.1.10
|
||||
Sequence |
MEKTQETVQRILLEPYKYLLQLPGKQVRTKLSQAFNHWLKVPEDKLQIIIEVTEMLHNAS
LLIDDIEDNSKLRRGFPVAHSIYGIPSVINSANYVYFLGLEKVLTLDHPDAVKLFTRQLL ELHQGQGLDIYWRDNYTCPTEEEYKAMVLQKTGGLFGLAVGLMQLFSDYKEDLKPLLNTL GLFFQIRDDYANLHSKEYSENKSFCEDLTEGKFSFPTIHAIWSRPESTQVQNILRQRTEN IDIKKYCVHYLEDVGSFEYTRNTLKELEAKAYKQIDARGGNPELVALVKHLSKMFKEENE |
||||
Inhibitor | (2E, 6E)-farnesylbisphosphonate | Drug Info | [529074] | ||
3-azageranylgeranyl diphosphate | Drug Info | [526333] | |||
BPH-252 | Drug Info | [529700] | |||
BPH-608 | Drug Info | [528871] | |||
BPH-628 | Drug Info | [529700] | |||
BPH-629 | Drug Info | [528871] | |||
BPH-675 | Drug Info | [528871] | |||
BPH-676 | Drug Info | [528871] | |||
BPH-715 | Drug Info | [529700] | |||
BPH-742 | Drug Info | [529700] | |||
compound 11 | Drug Info | [529700] | |||
compound 12 | Drug Info | [526333] | |||
compound 14 | Drug Info | [529700] | |||
compound 16 | Drug Info | [529700] | |||
compound 19 | Drug Info | [529700] | |||
compound 47 | Drug Info | [529700] | |||
compound 51 | Drug Info | [529700] | |||
CT-10 | Drug Info | [543909] | |||
digeranyl bisphosphonate | Drug Info | [529700] | |||
minodronic acid | Drug Info | [529700] | |||
PG-1014491 | Drug Info | [543909] | |||
Pathways | |||||
BioCyc Pathway | Superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate) | ||||
Superpathway of cholesterol biosynthesis | |||||
Trans, trans-farnesyl diphosphate biosynthesis | |||||
Geranylgeranyldiphosphate biosynthesis | |||||
KEGG Pathway | Terpenoid backbone biosynthesis | ||||
Metabolic pathways | |||||
Biosynthesis of antibiotics | |||||
PANTHER Pathway | Cholesterol biosynthesis | ||||
PathWhiz Pathway | Steroid Biosynthesis | ||||
Reactome | Cholesterol biosynthesis | ||||
Activation of gene expression by SREBF (SREBP) | |||||
WikiPathways | Activation of Gene Expression by SREBP (SREBF) | ||||
References | |||||
Ref 526333 | Inhibition of geranylgeranyl diphosphate synthase by bisphosphonates and diphosphates: a potential route to new bone antiresorption and antiparasitic agents. J Med Chem. 2002 May 23;45(11):2185-96. | ||||
Ref 528871 | Bisphosphonates target multiple sites in both cis- and trans-prenyltransferases. Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10022-7. Epub 2007 May 29. | ||||
Ref 529074 | Mono- and dialkyl isoprenoid bisphosphonates as geranylgeranyl diphosphate synthase inhibitors. Bioorg Med Chem. 2008 Jan 1;16(1):390-9. Epub 2007 Sep 18. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.